Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Publication year range
1.
J Med Virol ; 23(3): 303-9, 1987 Nov.
Article in English | MEDLINE | ID: mdl-2828526

ABSTRACT

The influence of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), caffeic acid oxidation product (KOP), and trisodiumphosphonoformate (TPF) on the course of the primary cutaneous herpes simplex virus infection was investigated by means of a guinea pig test model. The antiviral substances were applied in an ointment with 10% urea as a penetration mediator. When the treatment was initiated 15 minutes after virus inoculation, 3% BVDU effectively inhibited the development of herpetic vesicles and 0.1% BVDU prevented the appearance of herpetic satellites. Under the same conditions 1% and 3% KOP ointments inhibited the appearance of satellites; and 0.5% TPF ointment completely inhibited the development of cutaneous herpes lesions. Prophylactic drug administration given 24, 20, and 4 hours before virus inoculation was without any protective effect.


Subject(s)
Antiviral Agents/therapeutic use , Bromodeoxyuridine/analogs & derivatives , Caffeic Acids/therapeutic use , Cinnamates/therapeutic use , Herpes Simplex/drug therapy , Organophosphorus Compounds/therapeutic use , Phosphonoacetic Acid/therapeutic use , Animals , Bromodeoxyuridine/therapeutic use , Female , Foscarnet , Guinea Pigs , Humans , Male , Oxidation-Reduction , Phosphonoacetic Acid/analogs & derivatives , Simplexvirus/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL